Population
Patients with hypertension
Design
Review
Authors
Loading...
Supports ARB use via targeted mechanism in hypertension; leaves open comparative outcome data versus alternatives in broad populations.
AT1-receptor blockers offer a targeted approach to antihypertensive therapy by specifically blocking the effects of angiotensin II at the AT1 receptor.
Oliverio et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: